C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
RRD VA
Grant: I01 RX001141
NIBIB NIH HHS
Grant: R01 EB022040
NIAID NIH HHS
Grant: U01 AI132894
NIDDK NIH HHS
Grant: P30 DK123704
NIAID NIH HHS
Grant: R01 AI154959
BLRD VA
Grant: IK6 BX005235
NIAMS NIH HHS
Grant: R01 AR051749
BLRD VA
Grant: I01 BX004256
National Institutes of Health
MeSH Terms
Keywords